Log In
BCIQ
Print this Print this
 

Neo-GAA, neoGAA (GZ402666)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSecond-generation recombinant human acid alpha glucosidase (GAA)
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationPompe's disease
Indication DetailsTreat Pompe's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today